Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Medical Countermeasures

    National Preparedness and Response Science Board Meeting

    By Global Biodefense StaffMarch 24, 2015
    BioWatch Trigger Detector
    Share
    Facebook LinkedIn Reddit Email

    The National Preparedness and Response Science Board (NPRSB), also known as the National Biodefense Science Board, will be holding a public teleconference on March 30, 2015, from 1:00 p.m. to 2:00 p.m. EST.

    Individuals who wish to participate should send an email to NPRSB@HHS.GOV with ‘‘NPRSB Registration’’ in the subject line. The meeting will occur by teleconference. To attend via teleconference and for further instructions, please visit the NPRSB Web site at WWW.PHE.GOV/NPRSB.

    The Board is designated to provide expert advice and guidance on scientific, technical, and other matters of special interest to HHS regarding current and future chemical, biological, nuclear, and radiological agents, whether naturally occurring, accidental, or deliberate.

    This public meeting via teleconference will be dedicated to the NPRSB’s deliberation and vote on the findings from the ASPR Future Strategies Working Group. Subsequent agenda topics will be added as priorities dictate. Any additional agenda topics will be available on the meeting web page.

    Members of the public are invited to attend by teleconference via a toll-free call-in phone number which is available at WWW.PHE.GOV/NPRSB. All members of the public are encouraged to provide written comment to the NPRSB prior to March 29, 2015, and should be sent by email to nprsb@hhs.gov with ‘‘NPRSB Public Comment’’ as the subject line.

    Public comments received by close of business one week prior to each teleconference will be distributed to the NPRSB in advance.

    ASPR Bioterrorism BioWatch Events HHS
    Share. Facebook LinkedIn Reddit Email
    Previous ArticlePublic Comment Sought on Impact of Select Agent Regulations
    Next Article NIH REACH Program to Speed Commercialization of Health Technologies

    Related Stories

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Healthcare Workers Express Outrage at Flawed CDC Mask Guidance

    September 18, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.